Letter: Vedolizumab for the Management of Inflammatory Bowel Disease in Patients After Liver Transplantation for Primary Sclerosing Cholangitis

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.13861
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Letter: Vedolizumab for Autoimmune Liver Disease Associated Inflammatory Bowel Disease-Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Primary Sclerosing Cholangitis With Inflammatory Bowel Disease in Korean Children

Pediatric Gastroenterology, Hepatology and Nutrition
Child HealthHepatologyPediatricsPerinatologyGastroenterology
2015English

The Use of Biologics in Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis

Current Hepatology Reports
2019English

Gut and Liver B Cells of Common Clonal Origin in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease

Hepatology Communications
Hepatology
2018English

Ulcerative Colitis Has an Aggressive Course After Orthotopic Liver Transplantation for Primary Sclerosing Cholangitis

Gut
Gastroenterology
1998English

Surveillance for Hepatobiliary Cancers in Patients With Primary Sclerosing Cholangitis

Hepatology
MedicineHepatology
2018English

Primary Sclerosing Cholangitis

2017English

Editorial: The Role of Colonic Inflammation in the Progression of Liver Disease in Patients With Primary Sclerosing Cholangitis

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Primary Sclerosing Cholangitis

2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy